Skip to main content

Advertisement

ADVERTISEMENT

SmartTrak x Wound Care Collaboration News

News
11/04/2024
The state of Minnesota approved Solventum’s request for up to $13MM in assistance for the $209MM headquarters project at a former Blue Cross building in Eagan, MN. The company plans to upgrade and outfit its 250,000 square foot future home in...
The state of Minnesota approved Solventum’s request for up to $13MM in assistance for the $209MM headquarters project at a former Blue Cross building in Eagan, MN. The company plans to upgrade and outfit its 250,000 square foot future home in...
The state of Minnesota approved...
11/04/2024
Wound Care
News
11/04/2024
SNN experienced double-digit Skin Substitute growth driven by the launch of GRAPHIX PLUS in Q224, which is a new easier to handle version in its lead product family, targeting the growing post-acute market. SNN Q324 Earnings Transcript on...
SNN experienced double-digit Skin Substitute growth driven by the launch of GRAPHIX PLUS in Q224, which is a new easier to handle version in its lead product family, targeting the growing post-acute market. SNN Q324 Earnings Transcript on...
SNN experienced double-digit...
11/04/2024
Wound Care
News
11/04/2024
A case series of venous leg ulcers treated with human keratin matrix (HKM) with SoC showed significant size reduction in the very large VLUs in 4-5 weeks and in the smaller VLUs by week 8, suggesting that HKM has a beneficial effect on VLU...
A case series of venous leg ulcers treated with human keratin matrix (HKM) with SoC showed significant size reduction in the very large VLUs in 4-5 weeks and in the smaller VLUs by week 8, suggesting that HKM has a beneficial effect on VLU...
A case series of venous leg...
11/04/2024
Wound Care

Advertisement

News
11/04/2024
An analysis of 8,856 Medicaid beneficiaries with DFUs found patients who transitioned to commercial insurance had a lower risk of major amputation vs those with continuous Medicaid coverage (2.6% vs 3.2%, p less than 0.05). Diabetology
An analysis of 8,856 Medicaid beneficiaries with DFUs found patients who transitioned to commercial insurance had a lower risk of major amputation vs those with continuous Medicaid coverage (2.6% vs 3.2%, p less than 0.05). Diabetology
An analysis of 8,856 Medicaid...
11/04/2024
Wound Care
News
11/04/2024
A 105-patient single-arm study will evaluate the incidence of SSI within 90 days of surgery in high-risk revision patients undergoing total hip or knee joint arthroplasty who use Molnlycke Avance Solo NPWT post-surgically. Estimated...
A 105-patient single-arm study will evaluate the incidence of SSI within 90 days of surgery in high-risk revision patients undergoing total hip or knee joint arthroplasty who use Molnlycke Avance Solo NPWT post-surgically. Estimated...
A 105-patient single-arm study...
11/04/2024
Wound Care
News
11/04/2024
The CEO of MiMedx commented that CMS spending for skin substitutes in the private office and associated care settings is now running at a rate north of $1B per month. Five years ago, the total annual spend was closer to $500MM. MDGX Q324...
The CEO of MiMedx commented that CMS spending for skin substitutes in the private office and associated care settings is now running at a rate north of $1B per month. Five years ago, the total annual spend was closer to $500MM. MDGX Q324...
The CEO of MiMedx commented that...
11/04/2024
Wound Care

Advertisement

News
11/04/2024
Spectral AI announces the final group of burn center patients in the company’s US Burn Pivotal Study have successfully completed their clinical visits. The company expects to report topline results from this study in Dec 2024.
Spectral AI announces the final group of burn center patients in the company’s US Burn Pivotal Study have successfully completed their clinical visits. The company expects to report topline results from this study in Dec 2024.
Spectral AI announces the final...
11/04/2024
Wound Care
News
11/04/2024
This review examines the emerging technological advancements in treating chronic wounds that include 3D printing, microneedle array-based therapies, gene therapy (miRNAs), and smart wound dressings, among others. ACS Appl Bio
This review examines the emerging technological advancements in treating chronic wounds that include 3D printing, microneedle array-based therapies, gene therapy (miRNAs), and smart wound dressings, among others. ACS Appl Bio
This review examines the...
11/04/2024
Wound Care
News
10/23/2024
DEBx Medical has initiated a 40-patient pilot RCT to examine the safety/efficacy of chemical debridement and curettage in treatment of venous and mixed etiology leg ulcers with primary outcome of percentage wound reduction at 12 weeks. Not...
DEBx Medical has initiated a 40-patient pilot RCT to examine the safety/efficacy of chemical debridement and curettage in treatment of venous and mixed etiology leg ulcers with primary outcome of percentage wound reduction at 12 weeks. Not...
DEBx Medical has initiated a...
10/23/2024
Wound Care

Advertisement

News
10/23/2024
Tactile Medical announces the launch of the next-generation NIMBL pneumatic compression lymphedema platform in the U.S. for the treatment of upper extremity lymphedema. Nimbl is 68% lighter and 40% smaller than previous-generation devices.
Tactile Medical announces the launch of the next-generation NIMBL pneumatic compression lymphedema platform in the U.S. for the treatment of upper extremity lymphedema. Nimbl is 68% lighter and 40% smaller than previous-generation devices.
Tactile Medical announces the...
10/23/2024
Wound Care

Advertisement